Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:547-552

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lerner, D. L.
Right arrow Articles by Saffitz, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lerner, D. L.
Right arrow Articles by Saffitz, J. E.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies

(Circulation. 2000;101:547.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Accelerated Onset and Increased Incidence of Ventricular Arrhythmias Induced by Ischemia in Cx43-Deficient Mice

Deborah L. Lerner, MD; Kathryn A. Yamada, PhD; Richard B. Schuessler, PhD; Jeffrey E. Saffitz, MD, PhD

From the Departments of Pediatrics, Medicine, Surgery, and Pathology, and The Center for Cardiovascular Research, Washington University School of Medicine, St Louis, Mo.

Correspondence to Jeffrey E. Saffitz, MD, PhD, Department of Pathology, Box 8118, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110. E-mail saffitz{at}pathology.wustl.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Myocardial ischemia causes profound changes in both active membrane currents and passive electrical properties. Because these complex changes develop and progress concomitantly, it has not been possible to elucidate the relative contributions of any one component to arrhythmogenesis induced by acute ischemia. Cx43+/- mice express 50% of the normal level of connexin43 (Cx43), the major ventricular electrical coupling protein, but are otherwise identical to wild-type (Cx43+/+) mice. Comparison of arrhythmogenesis in Cx43+/- and +/+ mice can provide insights into the role of changes in electrical coupling as an independent variable in the complex setting of acute ischemia.

Methods and Results—Acute ischemia was induced in isolated perfused mouse hearts by occlusion of the left anterior descending coronary artery. Spontaneous ventricular tachyarrhythmias (VT) occurred in more than twice as many Cx43+/- hearts than Cx43+/+ hearts. VT was induced in nearly 3 times as many Cx43+/- hearts. Multiple runs and prolonged runs of spontaneous VT were more frequent in Cx43+/- hearts. Onset of the first run of VT occurred significantly earlier in Cx43+/- hearts. Premature ventricular beats were also more frequent in Cx43+/- hearts. The size of the hypoperfused region was equivalent in both groups.

Conclusions—Reduced expression of Cx43 accelerates the onset and increases the incidence, frequency, and duration of ventricular tachyarrhythmias after coronary artery occlusion. Thus diminished electrical coupling per se plays a critical role in arrhythmogenesis induced by acute ischemia.


Key Words: arrhythmia • conduction • electrophysiology • ischemia


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Sudden cardiac death has been described as an "electrical accident" that arises from complex, highly variable interactions between anatomic/functional myocardial substrates, transient initiating events, and cellular/tissue arrhythmia mechanisms.1 For example, malignant ventricular arrhythmias arising in the setting of acute myocardial ischemia are fundamentally related to marked reductions in tissue pH, increases in interstitial potassium and intracellular calcium levels, and neurohumoral changes, all of which interact in a complex, integrative pathophysiological milieu to slow conduction, alter excitability and refractoriness, promote electrical uncoupling, and generate spontaneous electrical activity.1 2 3 Increasingly sophisticated computer models of cardiac myocyte electrophysiology and metabolism have been useful in sorting out the contributions of alterations in specific proteins, channels, currents, or pathophysiological processes in arrhythmogenesis.4 5 However, gaining insights into the specific roles of individual determinants of arrhythmias in experimental systems involving real cardiac cells and tissues has not been possible previously.

Recent development of mouse models in which expression of specific gene products has been manipulated genetically provides an opportunity to define the roles of specific proteins in complex pathophysiological processes such as arrhythmogenesis induced by acute ischemia. We have previously studied mice6 7 in which expression of connexin43 (Cx43), the major ventricular gap junction protein, has been knocked out by homologous recombination.8 In contrast to Cx43-null animals, which die at birth, heterozygotes (Cx43+/-) survive and breed. Active membrane properties appear to be identical in Cx43-deficient (Cx43+/-) and wild-type (Cx43+/+) ventricular myocytes.6 However, Cx43+/- mice exhibit slow ventricular conduction that appears to be attributable solely to diminished coupling caused by expression of only 50% of the wild-type level of Cx43.6 7

We characterized ventricular tachyarrhythmias (VT) in isolated perfused mouse hearts subjected to left anterior descending (LAD) coronary occlusion. Comparison of wild-type and Cx43-deficient mice under identical conditions provided a means to investigate electrical coupling as an independent variable in arrhythmogenesis in the complex setting of acute ischemia. Using this approach, we found that diminished electrical coupling per se accelerates the onset and increases the incidence of tachyarrhythmias induced by acute ischemia.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cx43-Deficient and Wild-Type Mice
Hearts were isolated from 12- to 24-week-old mice produced from founders (B6,129-Gja1tm1Kdr) originally purchased from the Jackson Laboratories (Bar Harbor, Me) and maintained in an inbred background. Mice were housed in barrier facilities under strict veterinary supervision. Genotypes were determined by polymerase chain reaction as previously described,8 modified only by changing the sequence of the neoprimer (5'-AGGATCTCGTCGTGACCCAT-GGCGA-3') to minimize primer-dimer formation. Experimental protocols were approved by the Animal Studies Committee of Washington University School of Medicine.

Isolated Perfused Mouse Heart Preparation
An ex vivo model of acute ischemia was studied because it was more practical to occlude the LAD and record arrhythmias in isolated hearts. Accordingly, mice were anesthetized with sodium pentobarbital (150 mg/kg IP), and their hearts were rapidly excised and placed in oxygenated Krebs-Henseleit buffer containing (in mmol/L): NaCl 118.3, KCl 2.7, MgSO4 1.0, KH2PO4 1.4, NaHCO3 29.0, CaCl2 3.4, and glucose 10, plus insulin 70 mU/L and BSA 2.8%, at 37°C. Hearts were perfused by retrograde aortic flow with oxygenated buffer at 37°C. Flow rates were adjusted to maintain constant perfusion pressures of 45 to 50 mm Hg. Hearts were simultaneously superfused in a bath containing oxygenated buffer at 37°C to maintain constant temperature.

All hearts were perfused with oxygenated buffer for an initial 20-minute equilibration period. Any heart that demonstrated contractile dysfunction or other evidence of injury was discarded. Two groups of hearts were studied after the 20-minute stabilization interval. One group of 5 Cx43+/- and 5 Cx43+/+ hearts was perfused with oxygenated buffer for an additional 60 minutes and served as controls for the hearts subjected to coronary occlusion. Another group of 16 Cx43+/- and 16 Cx43+/+ hearts was subjected to acute regional ischemia of the apical and anterolateral left ventricle for 60 minutes by ligating the LAD immediately distal to its origin with 8-0 Prolene suture. Perfusion flow rates were adjusted after coronary occlusion to maintain perfusion pressures of 45 to 50 mm Hg. Studies of Cx43+/- and +/+ hearts were randomized and performed with the investigators blinded to the genotypes of the animals.

To assess the size and distribution of the hypoperfused region, hearts were arrested in diastole by perfusion with KCl (40 mEq/L) and then perfused with 0.1 mL of 2% lissamine green dye to stain the perfused regions. Hearts were fixed in 10% formalin for 24 hours and cut in 1-mm-thick transverse (short-axis) slices from the apex to the base. The basal cut surface of each slice was photographed and the areas of the entire left ventricular cut surface (including free walls and interventricular septum) and the hypoperfused (unstained) portion were measured with the use of computer-assisted planimetry. The area of the hypoperfused region was calculated as a percentage of total left ventricular tissue area.

Electrophysiological Recordings and Programmed Electrical Stimulation
During the initial 20-minute stabilization interval of oxygenated perfusion, a linear array of 8 bipolar extracellular electrodes was placed on the epicardial surface of the right atrium and anterior right ventricle along the maximum apical-basal dimension in an orientation approximately parallel to the longitudinal axis of the epicardial fibers. Data were recorded simultaneously at a gain of 1000 and frequency response of 50 to 1000 Hz. Signals were digitized at 4000 Hz with 12-bit resolution. A bipolar pacing electrode was placed near the apex of the heart on the anterior epicardial surface of the right ventricle, a region outside of the anticipated zone of left ventricular ischemia created by LAD occlusion. Atrial and ventricular epicardial electrograms were monitored continuously during the 60-minute interval of coronary occlusion or control (normoxic) perfusion.

At the end of the 20-minute stabilization interval in both control and coronary occlusion groups and again at subsequent 30-, 45-, and 60-minute time points, spontaneous cycle length was measured and programmed electrical stimulation was used to measure the effective refractory period and in an attempt to induce VT. Programmed right ventricular stimulation was performed by delivering a train of 8 beats at a basic cycle length of 130 ms (S1s) followed by delivery of a single premature beat (S2). S2 was decremented by 5-ms in multiple runs to determine the effective refractory period. Attempts were made to induce ventricular tachycardia with single extrastimuli down to a coupling interval of 20 ms and with ventricular burst pacing (18 S1s) at intervals of 20 to 80 ms until 1:1 capture was achieved. This protocol was repeated 3 times at each cycle length. Throughout these procedures, hearts were continuously monitored for premature ventricular beats (PVBs) and VT. Induced or spontaneously occurring PVBs and VT were recorded and analyzed. A run of VT was defined as 10 or more beats with a cycle length <100 ms. The number, time of onset, and duration of these events were tabulated for each heart. Both spontaneous and induced arrhythmias were tabulated to maximize opportunities to compare arrhythmogenesis in Cx43+/- and +/+ hearts.

Statistical Analyses
All data are expressed as mean±SD. Comparisons of the incidence, frequency, and duration of VT in Cx43+/- and +/+ hearts were made with the Pearson {chi}2 test. Continuous data such as cycle length and effective refractory period were compared with the use of ANOVA. Multiple comparisons between groups were made with Fisher’s least significant differences method. The time of onset of the first PVB or the first run of VT was analyzed by the Kaplan-Meier method, and comparisons between Cx43+/- and +/+ hearts were made with the Mantel log-rank test. A value of P<0.05 was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Electrophysiological Stability of the Isolated Perfused Mouse Heart
All control hearts (not subjected to coronary occlusion) remained in sinus rhythm and contracted vigorously throughout the 60-minute perfusion interval. Spontaneous cycle lengths were equivalent in control hearts of both genotypes and increased by {approx}50 ms over the 60-minute interval (Table 1Down). Effective refractory periods did not change during perfusion. The effective refractory period was modestly lower in Cx43+/- compared with Cx43+/+ hearts, but this difference achieved statistical significance only at the initial 0-minute time point. A single PVB was recorded in only 1 of 5 Cx43+/+ hearts during the entire 60-minute normoxic perfusion period. Of the 5 Cx43+/- hearts, 1 developed 1 PVB, 1 developed 2 PVBs, and 1 exhibited >20 premature beats during the 60-minute perfusion period. No runs of spontaneous or pacing-induced VT occurred in any control Cx43+/- or +/+ hearts. These observations indicate that the isolated perfused mouse heart preparation is electrically stable during oxygenated perfusion for 60 minutes.


View this table:
[in this window]
[in a new window]
 
Table 1. Cycle Length and Effective Refractory Period in Control Hearts

Electrophysiological Changes in Cx43+/- and Cx43+/+ Hearts Induced by Acute Regional Ischemia
The LAD was occluded in 16 Cx43+/- and 16 Cx43+/+ hearts, producing acute ischemia of the apical and anterolateral left ventricle. Spontaneous cycle lengths and effective refractory periods measured immediately before coronary artery occlusion in these hearts were similar to those shown in Table 1Up for control hearts at the 0-minute time point. During the subsequent 60 minutes of regional hypoperfusion, spontaneous cycle lengths became prolonged and the effective refractory periods became shorter, but no significant differences in these values between Cx43+/- and Cx43+/+ hearts occurred during the 60-minute interval of ischemia. Cycle lengths and effective refractory periods could not be determined in every heart at all time points because some exhibited persistent arrhythmias.

VT occurred in both Cx43+/- and +/+ ischemic hearts. Figure 1Down shows pairs of simultaneously recorded right atrial and ventricular electrograms and illustrates examples of the types of arrhythmias observed after coronary artery occlusion. Figure 1ADown demonstrates PVBs and a brief run of VT that initiated and terminated spontaneously. Figure 1BDown shows a polymorphic tachycardia with variable cycle lengths (53 to 74 ms) and electrogram morphology. Figure 1CDown shows a monomorphic tachycardia with uniform cycle lengths (55 to 60 ms) and electrogram morphology. VT cycle lengths were equivalent in the Cx43+/- and +/+ hearts with arrhythmias (62±12 and 59±7 ms, respectively, P>0.5). The great majority of tachycardias terminated spontaneously. In a few cases (<5%), the tachycardia was terminated by the introduction of an extrastimulus.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 1. Examples of arrhythmias in isolated perfused mouse hearts after coronary artery occlusion. Each panel shows pairs of right atrial (Atr) and ventricular (Ven) epicardial electrograms recorded simultaneously. A, Premature ventricular beats (arrows) and a short ({approx}1 second) run of VT that initiated and terminated spontaneously. The absence of a ventricular beat after the second atrial beat suggests a long refractory period after the PVB. B, Run of spontaneous polymorphic VT (cycle lengths from 53 to 74 ms). C, Run of spontaneous monomorphic VT (cycle lengths from 55 to 60 ms). Bar=100 ms.

Ventricular Tachyarrhythmias in Cx43+/- and Cx43+/+ Hearts
Figure 2Down shows the incidence of VT in Cx43+/- and Cx43+/+ hearts after LAD occlusion. Of the 16 hearts in each group, 12 Cx43+/- and 7 Cx43+/+ hearts had at least 1 run of either spontaneous or pacing-induced VT (Figure 2ADown). In addition, 11 Cx43+/- hearts had multiple (>1) runs of VT compared with only 5 Cx43+/+ hearts (P<0.05). Four Cx43+/- hearts exhibited nearly continuous bursts of VT with minimal intervening sinus rhythm during the final 30 minutes of ischemia compared with none of the wild-type hearts. Twelve of 16 Cx43+/- hearts had at least 1 run of sustained VT that lasted >3 seconds. The majority of these runs persisted for >20 seconds. In contrast, only 4 Cx43+/+ hearts had at least 1 run of sustained VT, and only 1 of these runs lasted >20 seconds.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Incidence, frequency, and duration of spontaneous and/or pacing-induced VT after coronary artery occlusion in Cx43+/+ and +/- hearts (n=16 for each group). * P<0.05, {dagger}P<0.01 by {chi}2 analysis.

Significant differences in the incidence, frequency, and duration of spontaneous and inducible VT occurred in the 2 groups (Figures 2BUp and C). Spontaneous VT occurred in more than twice as many Cx43+/- as +/+ hearts (Figure 2BUp). Nine of 16 Cx43+/- hearts had multiple runs of spontaneous VT compared with only 1 of 16 Cx43+/+ hearts (P<0.01); 8 Cx43+/- hearts had sustained runs of VT compared with only 1 Cx43+/+ heart (P<0.01). Pacing-induced ventricular tachycardias were observed in more Cx43+/- than +/+ hearts (P<0.01), and a greater number of Cx43+/- hearts exhibited multiple runs of inducible VT (P<0.05) (Figure 2CUp).

The time of onset of the first spontaneous VT after LAD occlusion occurred significantly earlier in Cx43+/- hearts (P<0.05) (Figure 3Down). Of the 9 Cx43+/- hearts that developed spontaneous tachycardia, 7 exhibited the first run of VT during the first 12 minutes after coronary artery occlusion. In contrast, the earliest onset of spontaneous VT in any Cx43+/+ heart did not occur until after 13 minutes of ischemia.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 3. Time of onset of the first spontaneous VT after coronary artery occlusion in Cx43+/+ and +/- hearts (n=16 for each group).

PVBs in Cx43+/- and Cx43+/+ Hearts
At least 1 PVB occurred at some point during the 60-minute interval of coronary occlusion in nearly all (15 of 16 Cx43+/- and 14 of 16 +/+) ischemic hearts, but the number of PVBs differed markedly between the 2 groups. The number of PVBs was counted for each preparation during each of the four 15-minute intervals of the entire 60-minute period of coronary occlusion. A maximum of 20 PVBs was tabulated for each 15-minute interval, although the presence of a greater number was noted. Generally, when the threshold of 20 PVBs was achieved, many more than 20 PVBs occurred. As shown in Table 2Down, 2 to 4 times as many Cx43+/- as Cx43+/+ hearts exceeded the threshold of >=20 PVBs during each 15-minute interval, but because sample sizes were small, only the difference at the 45-to-60-minute interval achieved statistical significance. However, 11 of 16 Cx43+/- compared with only 5 of 16 +/+ hearts developed >=20 PVBs during any 15-minute interval (P<0.05). Furthermore, 6 of 16 Cx43+/- hearts exceeded the threshold in 3 or all 15-minute intervals compared with only 1 of 16 Cx43+/+ hearts (P<0.05).


View this table:
[in this window]
[in a new window]
 
Table 2. No. of Hearts Exhibiting >=20 PVBs During 15-Minute Intervals of Ischemia

Figure 4Down shows a Kaplan-Meier plot of the time of ischemia at which the first PVB occurred. Although PVBs developed in nearly all hearts over the entire 60-minute interval of ischemia, analysis of the first 10 minutes of ischemia revealed significantly earlier onset in Cx43+/- hearts. During this initial interval, the first PVB occurred in 11 Cx43+/- hearts compared with only 5 Cx43+/+ hearts (P<0.05). These results suggest that diminished expression of Cx43 accelerates the onset and increases the frequency of PVBs during ischemia.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 4. Time of onset of the first PVB after coronary artery occlusion in Cx43+/+ and +/- hearts (n=16 for each group). During the first 10 minutes, significantly more Cx43+/- than Cx43+/+ hearts (P<0.05) developed the first PVB.

Size and Distribution of the Hypoperfused Region in Cx43+/- and Cx43+/+ Hearts
Examination of dye-stained hearts (n=6 for each genotype) revealed a large, clearly demarcated apical and anterolateral region of left ventricular hypoperfusion (Figure 5Down). The size of the hypoperfused (nonstained) region was equivalent in Cx43+/- and +/+ hearts (53±9% and 58±15% of the total left ventricular area, respectively, P>0.5). Thus enhanced arrhythmogenesis in Cx43+/- hearts was not the result of more extensive ischemic injury.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 5. Representative heart stained by dye perfusion showing a large region of hypoperfusion (pale unstained areas) involving the apex and anteroseptal and lateral free walls of the left ventricle. Bar=3 mm.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Altered electrical coupling has been strongly implicated in the development of arrhythmias induced by ischemia,1 2 3 4 9 10 11 12 but because multiple pathobiological responses to ischemia occur concomitantly, it has not been previously possible to elucidate the specific contributions of changes in coupling to arrhythmogenesis in acute myocardial ischemia. Comparison of wild-type and Cx43-deficient hearts allowed us to directly assess the effect of diminished Cx43 expression on arrhythmogenesis induced by ischemia without altering other influential factors at the same time. Our results provide strong, direct evidence that diminished electrical coupling caused by reduced expression of Cx43 accelerates the onset and increases the incidence, frequency, and duration of ventricular arrhythmias after acute regional ischemia. Although we have not formally excluded the possibilities that Cx43+/- hearts have a defect in another ion channel that becomes manifest only during ischemia or that adult Cx43+/- and +/+ myocytes may differ in active membrane properties, comparisons of action potential parameters and quantitative measures of voltage-gated Na+ channel protein expression and activity have revealed no differences in ventricular myocytes from neonatal Cx43+/- and +/+ mice.6 13

Ischemia-Induced VT and Altered Intercellular Coupling
Defining the role of specific gene products in arrhythmogenesis in mouse models of human diseases will require elucidation of arrhythmia mechanisms. Although analysis of arrhythmia mechanisms in mice will be technically challenging, Vaidya et al14 have observed stationary vortexlike reentry on the surface of a mouse heart induced by burst pacing and manifest in the ECG as sustained monomorphic tachycardia. Our observations in the present study are consistent with the hypothesis that reentrant circuits in Cx43+/- hearts may be more stable and inducible than in Cx43+/+ hearts. Modest conduction slowing under basal conditions in Cx43+/- hearts probably reduced the wavelength for reentry and further enhanced development of stable reentrant circuits when progressive regional uncoupling was induced by coronary occlusion. In a few cases, prolonged spontaneous tachycardias were easily terminated by a single extrastimulus, suggesting that the arrhythmias may have been reentrant. It should be stressed, however, that at least some of the arrhythmias observed in the present study could have arisen by nonreentrant mechanisms such as triggered activity, a mechanism that has been implicated in some monomorphic ventricular tachyarrhythmias in patients without organic heart disease.15 16

Accelerated onset of spontaneous VT in Cx43+/- mice supports the concept of a critical threshold of uncoupling in arrhythmogenesis. Cx43+/- hearts probably achieved a pathophysiological level of uncoupling and conduction slowing more rapidly than did Cx43+/+ hearts. Arrhythmias induced by acute ischemia occur in 2 phases, an initial wave (Ia) related in part to altered extracellular K+ levels, and a later wave (Ib) occurring 12 to 30 minutes after the onset of ischemia and related to electrical uncoupling.9 10 11 17 The time course of electrical uncoupling in response to ischemia has not been reported in mice, but the time course of arrhythmias observed in Cx43+/+ hearts is reminiscent of type Ib arrhythmias in pig hearts.11 Future studies will be required to determine whether the time course of uncoupling induced by ischemia differs in Cx43+/- and +/+ hearts.

Ischemia-Induced PVBs and Intercellular Coupling
Significantly more Cx43+/- than +/+ hearts had >=20 PVBs in at least one of the four 15-minute intervals and during 3 or all 15-minute intervals. Hearts that exceeded the threshold of 20 PVBs generally exhibited many more premature beats. Thus differences between Cx43+/- and +/+ hearts in the frequency of PVBs would undoubtedly have been greater if the actual number of PVBs had been counted. There was also a clear trend toward earlier onset of PVBs in ischemic Cx43+/- hearts. Premature ventricular beats may arise by reentry or be initiated by triggered activity. In the latter mechanism, a focal depolarization must be propagated to produce the premature beat. We do not yet know the mechanism responsible for the apparently greater number and earlier onset of PVBs in Cx43+/- mice after coronary occlusion, but our observations provide direct experimental evidence implicating altered coupling in the development and time of onset of PVBs during ischemia. The observations also raise intriguing questions about the potential pathophysiological links between changes in coupling and the development and propagation of PVBs initiated by either reentry or triggered activity.

Recent experimental observations and computer modeling studies have begun to delineate the effects of electrical coupling on both the initiation and propagation of triggered events.18 19 20 21 22 For example, Saiz et al22 showed in a modeling study that a moderate amount of uncoupling between normal myocardium and a region conducive to formation of early afterdepolarizations (EADs) (such as an area of acute ischemia) directly enhances both initiation of EADs and spread to neighboring tissue. They found that a specific degree of uncoupling could prolong repolarization and promote the generation of EADs and allow for a critical rise in membrane potential to achieve transfer of the impulse to the surrounding tissue. Our finding of increased PVBs in Cx43-deficient hearts is consistent with these computer models and provides experimental evidence potentially linking alterations in coupling with the generation and propagation of EADs. Future studies will be required to confirm the relation between diminished coupling and the development of PVBs to elucidate the specific mechanisms (reentry and/or triggered activity) responsible for PVBs and to characterize potential pathophysiological links between the development of PVBs and VT in mice with different baseline levels of intercellular coupling.

Clinical Implications
In view of the findings of the present study, it is logical to suggest that interventions designed to prevent uncoupling could diminish arrhythmogenesis during ischemia. Although such a strategy could limit the development of slow conduction and retard formation of arrhythmia substrates, it also could counteract potential benefits of uncoupling healthy and ischemic myocytes from each other. In this setting, uncoupling may be thought of as an adaptive process that isolates irreversibly injured cells from viable neighbors. Acute uncoupling may also electrically silence viable but injured regions and limit their contribution to arrhythmias dependent on slow conduction and unidirectional conduction block. Further investigation will be required to elucidate the potential benefits and risks of modulating cell-to-cell coupling and define the effects of total versus partial uncoupling in the pathogenesis of ischemia-induced arrhythmias.


*    Acknowledgments
 
This study was supported by National Institutes of Health grants HL-32257, HL-33722, and HL-58507 and a Grant-in-Aid from the American Heart Association and the Council on Clinical Cardiology. Dr Lerner was supported by National Institutes of Health Training Grant HL-07275. We thank Joseph M. Smith, MD, PhD, for a critical review of the manuscript and helpful discussions and Kenneth Schechtman, PhD, for assistance with statistical analysis.

Received May 19, 1999; revision received August 9, 1999; accepted August 17, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:2334–2351.[Free Full Text]

2. Kléber AG, Fleischauer J, Cascio WE. Ischemia-induced propagation failure in the heart. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:174–182.

3. Owens LM, Fralix TA, Murphy E, Cascio WE, Gettes LS. Correlation of ischemia-induced extracellular and intracellular ion changes to cell-to-cell electrical uncoupling in isolated blood-perfused rabbit hearts: experimental working group. Circulation. 1996;94:10–13.[Abstract/Free Full Text]

4. Shaw RM, Rudy Y. Electrophysiologic effects of acute myocardial infarction: a mechanistic investigation of action potential induction and conduction failure. Circ Res. 1997;80:124–138.[Abstract/Free Full Text]

5. Ch’en FF, Vaughan-Jones RD, Clarke K, Noble D. Modelling myocardial ischaemia and reperfusion. Prog Biophys Mol Biol. 1998;69:515–538.[Medline] [Order article via Infotrieve]

6. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE. Slow ventricular conduction in mice heterozygous for a Cx43 null mutation. J Clin Invest. 1997;99:1991–1998.[Medline] [Order article via Infotrieve]

7. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, Saffitz JE. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation. 1998;97:686–691.[Abstract/Free Full Text]

8. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Jeneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267:1831–1834.[Abstract/Free Full Text]

9. Kléber AG, Riegger CB, Janse MJ. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res. 1987;61:271–279.[Abstract/Free Full Text]

10. Riegger CB, Alperovich G, Kléber AG. Effects of oxygen withdrawal on active and passive electrical properties of arterially perfused rabbit ventricular muscle. Circ Res. 1989;64:532–541.[Abstract/Free Full Text]

11. Smith WT, Fleet WF, Johnson TA, Engle CL, Cascio WE. The Ib phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Circulation. 1995;92:3051–3060.[Abstract/Free Full Text]

12. Peters NS, Coromilas J, Severs NJ, Wit AL. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation. 1997;95:988–996.[Abstract/Free Full Text]

13. Johnson CM, Green KG, Kanter EM, Bou-Abboud E, Saffitz JE, Yamada KA. Voltage-gated Na+ channel activity and connexin expression in Cx43-deficient myocytes. J Cardiovasc Electrophysiol. 1999;10:1390–1401.[Medline] [Order article via Infotrieve]

14. Vaidya D, Morley GE, Samie FH, Jalife J. Reentry and fibrillation in the mouse heart: a challenge to the critical mass hypothesis. Circ Res. 1999;85:174–181.[Abstract/Free Full Text]

15. Buxton AE, Marchlinski FE, Doherty JU, Cassidy DM, Vassallo JA, Flores BT, Josephson ME. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients without organic heart disease. Am J Cardiol. 1984;54:997–1002.[Medline] [Order article via Infotrieve]

16. Brugada P, Wellens HJJ. The role of triggered activity in clinical ventricular arrhythmias. Pacing Clin Electrophysiol. 1984;7:260–271.[Medline] [Order article via Infotrieve]

17. Horaceck T, Neumann M, von Mutius S, Budden M, Meesman W. Nonhomogeneous electrophysiological changes and the bimodal distribution of early ventricular arrhythmias during acute coronary artery occlusion. Basic Res Cardiol. 1984;79:649–667.[Medline] [Order article via Infotrieve]

18. Li Z, Maldonado C, Zee-Cheng C, Hiromasa S, Kupersmith J. Conduction of early afterdepolarizations in sheep Purkinje fibers and ventricular muscle. J Electrocardiol. 1992;25:119–127.[Medline] [Order article via Infotrieve]

19. Saiz J, Ferrero JM, Ferrero JM, Roa LM, Thakor NV. Simulation of triggered activity and abnormal automaticity in ventricular myocytes. Proc Comput Cardiol. 1995;345–348.

20. Gibb WJ, Wagner MB, Lesh MD. Modelling triggered cardiac activity: an analysis of the interactions between potassium blockade, rhythm pauses, and cellular coupling. Math Biosci. 1996;137:101–133.[Medline] [Order article via Infotrieve]

21. Nordin C. Computer model of electrophysiological instability in very small heterogeneous ventricular syncytia. Am J Physiol. 1997;272:H1838–H1856.[Abstract/Free Full Text]

22. Saiz J, Ferrero JM, Monserrat M, Ferrero JM, Thakor NV. Influence of electrical coupling on early afterdepolarizations in ventricular myocytes. IEEE Trans Biomed Eng. 1999;46:138–146.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. L. Stables and M. J. Curtis
Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation
Cardiovasc Res, July 15, 2009; 83(2): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
V. Akoyev, S. Das, S. Jena, L. Grauer, and D. J. Takemoto
Hypoxia-Regulated Activity of PKC{epsilon} in the Lens
Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1271 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen
Ethanol for cardiac ischemia: the role of protein kinase c
Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 469 - 483.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
N. J. Severs, A. F. Bruce, E. Dupont, and S. Rothery
Remodelling of gap junctions and connexin expression in diseased myocardium
Cardiovasc Res, October 1, 2008; 80(1): 9 - 19.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Yang, Y. Lu, and Z. Wang
Control of cardiac excitability by microRNAs
Cardiovasc Res, September 1, 2008; 79(4): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Nakagami, H. Tanaka, P. Dai, S.-F. Lin, T. Tanabe, H. Mani, K. Fujiwara, H. Matsubara, and T. Takamatsu
Generation of reentrant arrhythmias by dominant-negative inhibition of connexin43 in rat cultured myocyte monolayers
Cardiovasc Res, July 1, 2008; 79(1): 70 - 79.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. B. Danik, G. Rosner, J. Lader, D. E. Gutstein, G. I. Fishman, and G. E. Morley
Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts
FASEB J, April 1, 2008; 22(4): 1204 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. F. Bruce, S. Rothery, E. Dupont, and N. J. Severs
Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1
Cardiovasc Res, March 1, 2008; 77(4): 757 - 765.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. M. Oxford, H. Musa, K. Maass, W. Coombs, S. M. Taffet, and M. Delmar
Connexin43 Remodeling Caused by Inhibition of Plakophilin-2 Expression in Cardiac Cells
Circ. Res., September 28, 2007; 101(7): 703 - 711.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Boengler, I. Konietzka, A. Buechert, Y. Heinen, D. Garcia-Dorado, G. Heusch, and R. Schulz
Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1764 - H1769.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
J. Li, V. V. Patel, and G. L. Radice
Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis.
Clin. Med. Res., March 1, 2006; 4(1): 42 - 52.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Betsuyaku, N. S. Nnebe, R. Sundset, S. Patibandla, C. M. Krueger, and K. A. Yamada
Overexpression of cardiac connexin45 increases susceptibility to ventricular tachyarrhythmias in vivo
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H163 - H171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. E. Gutstein, S. B. Danik, S. Lewitton, D. France, F. Liu, F. L. Chen, J. Zhang, N. Ghodsi, G. E. Morley, and G. I. Fishman
Focal gap junction uncoupling and spontaneous ventricular ectopy
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1091 - H1098.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ando, R. G. Katare, Y. Kakinuma, D. Zhang, F. Yamasaki, K. Muramoto, and T. Sato
Efferent Vagal Nerve Stimulation Protects Heart Against Ischemia-Induced Arrhythmias by Preserving Connexin43 Protein
Circulation, July 12, 2005; 112(2): 164 - 170.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Zhang, J. Cheng, G. Lam, D. K. Jin, L. Vincent, N. R. Hackett, S. Wang, L. M. Young, B. Hempstead, R. G. Crystal, et al.
Adenovirus Vector E4 Gene Regulates Connexin 40 and 43 Expression in Endothelial Cells via PKA and PI3K Signal Pathways
Circ. Res., May 13, 2005; 96(9): 950 - 957.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Zeevi-Levin, Y. D. Barac, Y. Reisner, I. Reiter, G. Yaniv, G. Meiry, Z. Abassi, S. Kostin, J. Schaper, M. R. Rosen, et al.
Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes
Cardiovasc Res, April 1, 2005; 66(1): 64 - 73.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. A. Iacobas, S. Iacobas, W. E. I. Li, G. Zoidl, R. Dermietzel, and D. C. Spray
Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart
Physiol Genomics, February 10, 2005; 20(3): 211 - 223.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Ai and S. M. Pogwizd
Connexin 43 Downregulation and Dephosphorylation in Nonischemic Heart Failure Is Associated With Enhanced Colocalized Protein Phosphatase Type 2A
Circ. Res., January 7, 2005; 96(1): 54 - 63.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. B. Danik, F. Liu, J. Zhang, H. J. Suk, G. E. Morley, G. I. Fishman, and D. E. Gutstein
Modulation of Cardiac Gap Junction Expression and Arrhythmic Susceptibility
Circ. Res., November 12, 2004; 95(10): 1035 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. S. Turner, G. A. Haywood, P. Andreka, L. You, P. E. Martin, W. H. Evans, K. A. Webster, and N. H. Bishopric
Reversible Connexin 43 Dephosphorylation During Hypoxia and Reoxygenation Is Linked to Cellular ATP Levels
Circ. Res., October 1, 2004; 95(7): 726 - 733.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Gros, L. Dupays, S. Alcolea, S. Meysen, L. Miquerol, and M. Theveniau-Ruissy
Genetically modified mice: tools to decode the functions of connexins in the heart--new models for cardiovascular research
Cardiovasc Res, May 1, 2004; 62(2): 299 - 308.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. R de Groot and R. Coronel
Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis
Cardiovasc Res, May 1, 2004; 62(2): 323 - 334.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. J. Severs, S. R. Coppen, E. Dupont, H.-I Yeh, Y.-S. Ko, and T. Matsushita
Gap junction alterations in human cardiac disease
Cardiovasc Res, May 1, 2004; 62(2): 368 - 377.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. R. de Groot, T. Veenstra, A. O. Verkerk, R. Wilders, J. P.P. Smits, F. J.G. Wilms-Schopman, R. F. Wiegerinck, J. Bourier, C. N.W. Belterman, R. Coronel, et al.
Conduction slowing by the gap junctional uncoupler carbenoxolone
Cardiovasc Res, November 1, 2003; 60(2): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. T. Maguire, H. Wakimoto, V. V. Patel, P. E. Hammer, K. Gauvreau, and C. I. Berul
Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies
Physiol Genomics, September 29, 2003; 15(1): 84 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Mancuso, D. R. Abendschein, C. M. Jenkins, X. Han, J. E. Saffitz, R. B. Schuessler, and R. W. Gross
Cardiac Ischemia Activates Calcium-independent Phospholipase A2{beta}, Precipitating Ventricular Tachyarrhythmias in Transgenic Mice: RESCUE OF THE LETHAL ELECTROPHYSIOLOGIC PHENOTYPE BY MECHANISM-BASED INHIBITION
J. Biol. Chem., June 13, 2003; 278(25): 22231 - 22236.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. K. Jain, R. B. Schuessler, and J. E. Saffitz
Mechanisms of Delayed Electrical Uncoupling Induced by Ischemic Preconditioning
Circ. Res., May 30, 2003; 92(10): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. E. I. Gittens, A. A. Mhawi, D. Lidington, Y. Ouellette, and G. M. Kidder
Functional analysis of gap junctions in ovarian granulosa cells: distinct role for connexin43 in early stages of folliculogenesis
Am J Physiol Cell Physiol, April 1, 2003; 284(4): C880 - C887.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kanno, A. Kovacs, K. A. Yamada, and J. E. Saffitz
Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice
J. Am. Coll. Cardiol., February 19, 2003; 41(4): 681 - 686.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
H.-I. Yeh, Y.-J. Lai, Y.-N. Lee, Y.-J. Chen, Y.-C. Chen, C.-C. Chen, S.-A. Chen, C.-I. Lin, and C.-H. Tsai
Differential Expression of Connexin43 Gap Junctions in Cardiomyocytes Isolated from Canine Thoracic Veins
J. Histochem. Cytochem., February 1, 2003; 51(2): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H.-I Yeh, S.-H. Hou, H.-R. Hu, Y.-N. Lee, J.-Y. Li, E. Dupont, S. R. Coppen, Y.-S. Ko, N. J. Severs, and C.-H. Tsai
Alteration of gap junctions and connexins in the right atrial appendage during cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1106 - 1112.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
B. G. Petrich, X. Gong, D. L. Lerner, X. Wang, J. H. Brown, J. E. Saffitz, and Y. Wang
c-Jun N-Terminal Kinase Activation Mediates Downregulation of Connexin43 in Cardiomyocytes
Circ. Res., October 4, 2002; 91(7): 640 - 647.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. M. Johnson, E. M. Kanter, K. G. Green, J. G. Laing, T. Betsuyaku, E. C. Beyer, T. H. Steinberg, J. E. Saffitz, and K. A. Yamada
Redistribution of connexin45 in gap junctions of connexin43-deficient hearts
Cardiovasc Res, March 1, 2002; 53(4): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
B.G. PETRICH, P. LIAO, and Y. WANG
Using a Gene-switch Transgenic Approach to Dissect Distinct Roles of MAP Kinases in Heart Failure
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 429 - 438.
[Abstract] [PDF]


Home page
CirculationHome page
H.-I Yeh, Y.-J. Lai, S.-H. Lee, Y.-N. Lee, Y.-S. Ko, S.-A. Chen, N. J. Severs, and C.-H. Tsai
Heterogeneity of Myocardial Sleeve Morphology and Gap Junctions in Canine Superior Vena Cava
Circulation, December 18, 2001; 104(25): 3152 - 3157.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Gutstein, G. E. Morley, D. Vaidya, F. Liu, F. L. Chen, H. Stuhlmann, and G. I. Fishman
Heterogeneous Expression of Gap Junction Channels in the Heart Leads to Conduction Defects and Ventricular Dysfunction
Circulation, September 4, 2001; 104(10): 1194 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. C Eloff, D. L Lerner, K. A Yamada, R. B Schuessler, J. E Saffitz, and D. S Rosenbaum
High resolution optical mapping reveals conduction slowing in connexin43 deficient mice
Cardiovasc Res, September 1, 2001; 51(4): 681 - 690.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. A.B. van Veen, H. V.M. van Rijen, and T. Opthof
Cardiac gap junction channels: modulation of expression and channel properties
Cardiovasc Res, August 1, 2001; 51(2): 217 - 229.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. O Verkerk, M. W Veldkamp, R. Coronel, R. Wilders, and A. C.G van Ginneken
Effects of cell-to-cell uncoupling and catecholamines on Purkinje and ventricular action potentials: implications for phase-1b arrhythmias
Cardiovasc Res, July 1, 2001; 51(1): 30 - 40.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. L Lerner, M. A Beardslee, and J. E Saffitz
The role of altered intercellular coupling in arrhythmias induced by acute myocardial ischemia
Cardiovasc Res, May 1, 2001; 50(2): 263 - 269.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. R de Groot, F. J.G Wilms-Schopman, T. Opthof, C. A Remme, and R. Coronel
Late ventricular arrhythmias during acute regional ischemia in the isolated blood perfused pig heart Role of electrical cellular coupling
Cardiovasc Res, May 1, 2001; 50(2): 362 - 372.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. E. Gutstein, G. E. Morley, H. Tamaddon, D. Vaidya, M. D. Schneider, J. Chen, K. R. Chien, H. Stuhlmann, and G. I. Fishman
Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43
Circ. Res., February 16, 2001; 88(3): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. E. Cascio, H. Yang, T. A. Johnson, B. J. Muller-Borer, and J. J. Lemasters
Electrical Properties and Conduction in Reperfused Papillary Muscle
Circ. Res., October 26, 2001; 89(9): 807 - 814.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lerner, D. L.
Right arrow Articles by Saffitz, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lerner, D. L.
Right arrow Articles by Saffitz, J. E.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies